Literature DB >> 21034181

Antidepressants in pregnancy: a systematic review.

Adaobi Udechuku1, Tram Nguyen, Rebecca Hill, Klara Szego.   

Abstract

Part of three systematic reviews on the effects of psychotropic medication exposure in pregnancy, this paper critically reviews the literature on adverse effects of antidepressant use during pregnancy, and derives recommendations for clinical practice. Electronic databases were searched for original research studies examining the effects of gestational exposure to antidepressants on pregnancy, neonatal and longer-term developmental outcomes. Most results were derived from cohort (prospective and retrospective) and casecontrol studies. There were no randomized controlled trials. Congenital malformations: 35 studies identified, 12 demonstrated a significant association between antidepressant use in early pregnancy and congenital malformations. Pregnancy outcomes: 35 articles identified, outcomes measured rates of spontaneous abortion (4 out of 7 studies reporting elevated risk), preterm birth (15 out of 19 reporting elevated risk) and abnormal birth weight (8 out of 23 reporting elevated risk). Neonatal outcomes: 17 controlled studies including one meta-analysis were identified concerning neonatal adaptation. 15 studies showed an association between gestational exposure to antidepressants and neonatal adaptation difficulties. Three studies examined an association between selective serotonin reuptake inhibitor (SSRI) exposure and persistent pulmonary hypertension in the neonate with conflicting results. Longer-term developmental outcomes: 6 of 7 studies comparing developmental outcomes of children exposed to antidepressants in utero with non- exposed children reported no significant differences. Most of these medications remain relatively safe in pregnancy, but some significant areas of concern exist, particularly some evidence of higher risk of preterm birth, neonatal adaptation difficulties and congenital cardiac malformations (with paroxetine). The impact of these findings on the risk-benefit analysis when treating pregnant women with antidepressants is discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034181     DOI: 10.3109/00048674.2010.507543

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  33 in total

Review 1.  [Anesthesia and pain management during pregnancy].

Authors:  T Ninke; S Thoma-Jennerwein; J Blunk; T Annecke
Journal:  Anaesthesist       Date:  2015-05       Impact factor: 1.041

Review 2.  Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature.

Authors:  Kathleen Szegda; Glenn Markenson; Elizabeth R Bertone-Johnson; Lisa Chasan-Taber
Journal:  J Matern Fetal Neonatal Med       Date:  2013-10-17

3.  Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.

Authors:  Christina L Boisseau; Steven A Rasmussen
Journal:  Contemp Clin Trials       Date:  2018-01-03       Impact factor: 2.226

4.  CALM Pregnancy: results of a pilot study of mindfulness-based cognitive therapy for perinatal anxiety.

Authors:  Janice H Goodman; Anthony Guarino; Kerry Chenausky; Lauri Klein; Joanna Prager; Rebecca Petersen; Avery Forget; Marlene Freeman
Journal:  Arch Womens Ment Health       Date:  2014-01-22       Impact factor: 3.633

Review 5.  The German guidelines for the treatment of anxiety disorders.

Authors:  Borwin Bandelow; Thomas Lichte; Sebastian Rudolf; Jörg Wiltink; Manfred E Beutel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-18       Impact factor: 5.270

6.  Prenatal Perceived Stress and Adverse Birth Outcomes Among Puerto Rican Women.

Authors:  Kathleen Szegda; Elizabeth R Bertone-Johnson; Penelope Pekow; Sally Powers; Glenn Markenson; Nancy Dole; Lisa Chasan-Taber
Journal:  J Womens Health (Larchmt)       Date:  2017-12-07       Impact factor: 2.681

7.  A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.

Authors:  Hsiang Huang; Shane Coleman; Jeffrey A Bridge; Kimberly Yonkers; Wayne Katon
Journal:  Gen Hosp Psychiatry       Date:  2013-10-02       Impact factor: 3.238

Review 8.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

9.  The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.

Authors:  William V Bobo; Richard A Epstein; Rachel M Hayes; Richard C Shelton; Tina V Hartert; Ed Mitchel; Jeff Horner; Pingsheng Wu
Journal:  Arch Womens Ment Health       Date:  2013-10-03       Impact factor: 3.633

Review 10.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.